BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2024 10:06:34 AM | Browse: 103 | Download: 212
 |
Received |
|
2024-01-28 17:21 |
 |
Peer-Review Started |
|
2024-01-28 17:21 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-03-05 04:50 |
 |
Revised |
|
2024-04-02 13:05 |
 |
Second Decision |
|
2024-04-11 02:33 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-04-11 07:31 |
 |
Articles in Press |
|
2024-04-11 07:31 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-05-27 15:42 |
 |
Publish the Manuscript Online |
|
2024-06-24 10:06 |
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Immunology |
Manuscript Type |
Review |
Article Title |
Harnessing immunity: Immunomodulatory therapies in COVID-19
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tsvetelina Velikova, Hristo Valkov, Anita Aleksandrova, Monika Peshevska-Sekulovska, Metodija Sekulovski and Russka Shumnalieva |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria |
BG-RRP-2.004-0008 |
|
Corresponding Author |
Russka Shumnalieva, MD, PhD, Adjunct Associate Professor, Department of Rheumatology, Clinic of Rheumatology, University Hospital "St. Ivan Rilski", Medical University-Sofia, Urvich Street 13, Sofia 1612, Bulgaria. rshumnalieva@yahoo.com |
Key Words |
Immunomodulation; COVID-19; Severe acute respiratory syndrome coronavirus 2; Immunotherapy; Antiviral immune response; Cytokine storm; Adaptive immunity; Therapeutic strategies; Immune modulators; Viral infection; Host immune response |
Core Tip |
Effective management of coronavirus disease 2019 (COVID-19) requires a nuanced approach that harnesses the host’s immune response Immunomodulatory therapies play a pivotal role in fine-tuning the immune system, striking a balance between defense and avoiding excessive inflammation. In line with this, increased precision in targeting specific immune pathways, alongside personalized treatment strategies, holds promise in optimizing outcomes for COVID-19 patients. This paper explores the evolving landscape of immunomodulation, emphasizing its potential as a crucial component in the therapeutic arsenal against the virus. |
Publish Date |
2024-06-24 10:06 |
Citation |
<p>Velikova T, Valkov H, Aleksandrova A, Peshevska-Sekulovska M, Sekulovski M, Shumnalieva R. Harnessing immunity: Immunomodulatory therapies in COVID-19. <i>World J Virol</i> 2024; 13(2): 92521</p> |
URL |
https://www.wjgnet.com/2220-3249/full/v13/i2/92521.htm |
DOI |
https://dx.doi.org/10.5501/wjv.v13.i2.92521 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345